AWH Logo

Aspira Women's Health Inc. (AWH) 

NASDAQ
Market Cap
$12.83M
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
271 of 960
Rank in Industry
14 of 52

Largest Insider Buys in Sector

AWH Stock Price History Chart

AWH Stock Performance

About Aspira Women's Health Inc.

Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing; and owns and operates …

Insider Activity of Aspira Women's Health Inc.

Over the last 12 months, insiders at Aspira Women's Health Inc. have bought $142,935 and sold $0 worth of Aspira Women's Health Inc. stock.

On average, over the past 5 years, insiders at Aspira Women's Health Inc. have bought $2.25M and sold $71,151 worth of stock each year.

Highest buying activity among insiders over the last 12 months: SCHULER JACK W (10 percent owner) — $658,500. Sandford Nicole (President & CEO) — $33,185.

The last purchase of 6,536 shares for transaction amount of $10,000 was made by SCHULER JACK W (10 percent owner) on 2024‑07‑09.

List of Insider Buy and Sell Transactions, Aspira Women's Health Inc.

2024-07-09Purchase10 percent owner
6,536
0.0674%
$1.53$10,000-25.00%
2024-05-31PurchaseChief Executive Officer
9,493
0.1549%
$2.42$22,973-61.13%
2024-01-26Purchase10 percent owner
28,500
0.6724%
$3.50$99,750-72.97%
2024-01-26PurchasePresident & CEO
2,400
0.0688%
$4.25$10,212-72.97%
2023-12-06SaleSecretary & General Counsel
980
0.0223%
$3.37$3,303-38.36%
2023-12-06PurchasePresident & CEO
5,000
0.1133%
$3.36$16,800-38.36%
2023-09-08PurchaseChief Financial Officer
2,246
0.0651%
$4.30$9,658-18.52%
2023-07-24Purchase10 percent owner
181,800
3.3703%
$2.75$499,950+41.43%
2023-07-24PurchasePresident & CEO
12,563
0.3371%
$3.98$50,001+41.43%
2023-07-24Purchasedirector
6,281
0.1685%
$3.98$24,998+41.43%
2023-07-24Purchasedirector
3,769
0.1011%
$3.98$15,001+41.43%
2023-07-24Purchasedirector
3,769
0.1011%
$3.98$15,001+41.43%
2023-07-24Purchasedirector
6,281
0.1685%
$3.98$24,998+41.43%
2023-07-24Purchasedirector
8,794
0.2359%
$3.98$35,000+41.43%
2023-07-24Purchasedirector
754
0.0202%
$3.98$3,001+41.43%
2023-07-24PurchaseCSO & COO
628
0.0168%
$3.98$2,499+41.43%
2023-07-24PurchaseGeneral counsel and secretary
754
0.0202%
$3.98$3,001+41.43%
2023-07-24PurchaseChief Financial Officer
754
0.0202%
$3.98$3,001+41.43%
2022-08-25Purchase
266,666
0.6741%
$0.38$100,000-26.00%
2022-08-25Purchase
13,332
$0$0-26.00%

Insider Historical Profitability

672.03%
Sandford NicoleChief Executive Officer
70596
0.4236%
$0.7750+1.54%
SCHULER JACK W10 percent owner
6536
0.0392%
$0.77190<0.0001%
FEINBERG LARRY N10 percent owner
9825289
58.9495%
$0.7730<0.0001%
Schuler Henri George10 percent owner
6047057
36.281%
$0.77162+5.15%
RATHMANN JAMES Ldirector
4391877
26.3503%
$0.7720

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.